<code id='8F10BCDE61'></code><style id='8F10BCDE61'></style>
    • <acronym id='8F10BCDE61'></acronym>
      <center id='8F10BCDE61'><center id='8F10BCDE61'><tfoot id='8F10BCDE61'></tfoot></center><abbr id='8F10BCDE61'><dir id='8F10BCDE61'><tfoot id='8F10BCDE61'></tfoot><noframes id='8F10BCDE61'>

    • <optgroup id='8F10BCDE61'><strike id='8F10BCDE61'><sup id='8F10BCDE61'></sup></strike><code id='8F10BCDE61'></code></optgroup>
        1. <b id='8F10BCDE61'><label id='8F10BCDE61'><select id='8F10BCDE61'><dt id='8F10BCDE61'><span id='8F10BCDE61'></span></dt></select></label></b><u id='8F10BCDE61'></u>
          <i id='8F10BCDE61'><strike id='8F10BCDE61'><tt id='8F10BCDE61'><pre id='8F10BCDE61'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:65
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          FDA grants conditional OK to Sarepta’s gene therapy for Duchenne
          FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

          KristofferTripplaar/SipaviaAPTheFoodandDrugAdministrationgrantedconditionalapprovalThursdaytothefirs

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Investigation reveals sickle cell patients pressured into sterilizations

          DearReaders,IwanttobringyourattentiontoadeeplydisturbingbutvitalseriesofstoriesSTATispublishingbegin